Around 65.4% of people over the age of 60 have hypertension, and it's the underlying cause of 6% of all fatalities globally. The left ventricle enlarges, or hypertrophies, in people with hypertension. If the left ventricle of the heart thickens its walls or the chamber of the left ventricle expands, or if both happen at once, the condition is called left ventricular hypertrophy (LVH) [1]. This condition impacts approximately 15 -20% of the general population and has similar rates in men and women. Serious health complications such as cardiovascular diseases, stroke, congestive heart failure, irregular heart rhythms (ventricular arrhythmias), and sudden cardiac death are linked to it.Rationale of the study: In people with slightly hypertensive conditions, the prevalence of LVH is 20%; in those with severe or complex hypertension, it approaches 100%. LVH is also a result of valve disorders, which cause pressure and/or volume overload. Furthermore, "physiological" LVH—which occurs in well-trained athletes in reaction to job overload—can arise. About 0.2% of the general population has hypertrophic cardiomyopathy, a hereditary condition caused by mutations in the sarcomere protein genes. It is characterized by severe cardiac tissue disarray, fibrotic scarring, and aberrant internal coronary arteries.Background and statement of the problem: Hypertension is a leading cause of many cardiovascular problems and cerebrovascular accidents Aim: Assessment of the Sokolowlyon’s Criteria of Left Ventricular Hypertrophy in comparison with Echocardiography Inhypertensives PatientsObjective: To determine whether the ECHO of left ventricular hypertrophy significantly coincides with the Sokolow Lyon criterion of the ECG.Methodology: This cross-sectional study was carried out at the Shree Balaji Medical College and Hospital's general medicine department in Chromepet, Tamil Nadu, India. The study ran from June 2022 to December 2023, a duration of eighteen months.Results: The study focused on assessing the correlation between Sokolow-Lyon criteria on (ECG) and (LVH) as determined by echocardiography (ECHO). The results revealed that among the 125 participants, 88 cases (70.40%) were identified as having LVH based on Sokolow-Lyon criteria, while 37 cases (29.60%) showed no signs of LVH. These findings provide a quantitative breakdown of the prevalence of LVH according to ECG criteria within the study population.Conclusion: Our investigation's findings showed that the ECG LVH Sokolow Lyon criteria had a satisfactory level of specificity and sensitivity in the diagnosis of left ventricular hypertrophy (LVH). The most sensitive diagnostic criteria turned out to be the ECG LVH Sokolow Lyon criteria, especially when it came to patients with co-morbidities. We found that the Sokolow Lyon criteria had a 36% sensitivity in the current investigation. As such, we suggest applying these criteria to assist in verifying the diagnosis of LVH, particularly in low-complexity healthcare environments without image-based diagnostic techniques like MRI and ECHO.
Read full abstract